ࡱ> RTKLMNOPQ7 zbjbjUU 17|7|zl::::t.nnnnnnnnoqqqqqq$ >nnnnnn6nn666n6@nno6no66h7.RHsUnb 0!t̝":0T@sUK03U@0sU6Appendix A Studies of the effects of high frequency electromagnetic fields on the cellular level Abbreviations neg. negative finding n.s. not statistically significant pos. positive finding s.s. statistically significant partly some findings # disagreement with the conclusions of the authors ? unknown; not provided; unreliable Table A.1 Genotoxic Effects of High Frequency Electromagnetic Fields Frequency ModulationPower Flux Density / SARExposure durationStudies subject / MethodResultRef.Direct DNA damage2,45 GHzcw10 20 W/m2 0,6 1,2 W/kg2 hRat, in vivopos., s.s.Lai & Singh 19952,45 GHzPM, 500 Hz10 20 W/m2 0,6 1,2 W/kg2 hRat, in vivopos., s.s.Lai & Singh 19952,45 GHzPM, cw20 W/m2 1,2 W/kg2 hRat, in vivopos., s.s.Lai & Singh 19962,45 GHzPM, 500 Hz20 W/m2 1,2 W/kg2 hRat, in vivopos., s.s.Lai & Singh 19962,45 GHzPM, 500 Hz20 W/m2 1,2 W/kg2 hRat, in vivopos., s.s.Lai & Singh 19972,45 GHzcw0,7 1,9 W/kg2 h 24 hGlioblastoma Cells (Human), in vitroneg.?Malyapa et al. 1997a2,45 GHzcw0,7 1,9 W/kg2 h 24 hFibroblasts (Mouse), in vitroneg.?Malyapa et al. 1997a836 848 MHzcw, FM, PM0,6 W/kg2 h 24 hGlioblastoma Cells (Human), in vitroneg.?Malyapa et al. 1997b836 848 MHz0,6 W/kg2 h 24 hFibroblasts (Mouse), in vitroneg.?Malyapa et al. 1997b2,45 GHzcw1,2 W/kg2 hRat (Brain), in vivo?Malyapa et al. 1998814 837 MHzPM, TDMA, 50 Hz8 90 W/m2 2,4 26 W/kg1 h 10,67 hT-Lymphoblastenpos., s.s.Phillips et al. 19982,45 GHzcw10 W/m2 1,18 W/kg120 d, 2 h/d 200 d, 2 h/dMouse (Brain, Testicles), in vivopos., s.s.Sarkar et al. 19941,7 GHzcw500 W/m230 minMouse (Testicles), in vivopos.Varma & Traboulay 1977Influences on DNA synthesis and repair350 MHzcw10 100 W/m2 0,039 4,5 W/kg1 h 3 hFibroblasts (Human), in vitrounclear, partly pos.Meltz et al. 1987350 MHzPM, 5,0 Hz10 100 W/m2 0,039 4,5 W/kg1 h 3 hFibroblasts (Human), in vitrounclear, partly pos.Meltz et al. 1987850 MHzcw10 100 W/m21 h 3 hFibroblasts (Human), in vitrounclear, partly pos.Meltz et al. 1987850 MHzPM, 5,0 Hz10 100 W/m21 h 3 hFibroblasts (Human), in vitrounclear, partly pos.Meltz et al. 19871,2 GHzcw10 100 W/m21 h 3 hFibroblasts (Human), in vitrounclear, partly pos.Meltz et al. 19871,2 GHzPM, 80 kHz10 100 W/m21 h 3 hFibroblasts (Human), in vitrounclear, partly pos.Meltz et al. 1987836,55 MHzPM, TDMA, 50 Hz0,9 90 W/m2 0,00015 - 0,059 W/kg4 h 14 dGlioma-Cells (Rat), in vitropos., s.s.Stagg et al. 1997Chromosome aberrations2,45 GHzcw??Mouse (bone marrow), in vivopos.Banerjee et al. 19832,45 GHzcw400 W/m26 d, 30 min/dRat, in vivopos.Beechey et al. 19867,7 GHzcw300 W/m215 - 60 minFibroblasts (Chin. Hamster), in vitropos., s.s.Garaj-Vrohac et al. 19907,7 GHzcw5 W/m215 - 60 minFibroblasts (Chin. Hamster), in vitropos., s.s.Garaj-Vrohac et al. 19917,7 GHzcw5 300 W/m210 minLymphocytes (Human), in vitropos., s.s.Garaj-Vrohac et al. 19920,4 MHz 20 GHzcw, AM, PMHuman, in vivopos.#, n.s.Garson et al. 19912,45 GHzPM, 25 kHz490 W/m2 33,8 W/kg2 hEgg Cells (Chinese Hamster)pos., partly s.s.Kerbacher et al. 19902,45 GHzcw104 193 W/kg20 minLymphocytes (Human), in vitroneg.Lloyd et al. 19842,45 GHzcw4 200 W/kg20 minLymphocytes (Human)neg.Lloyd et al. 19862,45 GHzcw75 W/kg30 120 minLymphocytes (Human), in vitropos.Maes et al. 1993954 MHPM, 217 Hz, GSMOccupational exposureLymphocytes, Human, in vivopos., s.s.Maes et al. 1995954 MHz217 Hz, GSM15 W/m2 1,5 W/kg2 hLymphocytes (Human), in vitropos., s.s.Maes et al. 1995935,2 MHzPM/GSM, 217 Hz0,3 0,4 W/kg2 hLymphocytes (Human), in vitropos., n.s.Maes et al. 19979,4 GHzPM, 1000 Hz1 100 W/m22 w, 3 d/w, 1 h/dMouse, in vivopos., s.s.Manikowska et al. 19792,45 GHzcw0,05 20 W/kg2 w, 6 d/w, 30 min/dMouse, in vivopos., s.s.Manikowska-Czerska et al. 19852,55 GHzcw2W/kg20 minDNA (E.coli), in vitropos.Sagripanti & Swicord 19862,0 8,75 GHzcw10 W/kg5 min 25 minDNA, in vitropos., s.s.Sagripanti et al. 19872,45 GHzcw100 W/m2120 d 6 h/dSpermatogonia (Mouse), in vivoneg.Saunders et al. 19882,45 GHzcw50 W/m2 12,46 W/kg90 minLymphocytes (Human), in vitropos., n.s.Vijayalaxmi et al. 19972,45 GHzcw750 W/m25 30 minChinese Hamster (Corneal Epithelium), in vivopos, s.s.Yao 19782,45 GHzcw15,2 W/kgRH5- and RH16-Cells (Kangaroo-Rat), in vitropos., s.s.Yao 1982Micronuclea154 162 MHzPM, 24,4 HzChanging exposures on the pasturesCow (Erythrocytes) in vivopos., s.s.Balode 19962,45 GHzCW530 W/m2 90 W/kg10 minLymphocytes (Human), in vitropos., partly s.s.d'Ambrosio et al. 19952,45AM, 50 Hz, sin530 W/m2 90 W/kg10 minLymphocytes (Human), in vitropos., partly s.s.d'Ambrosio et al. 19951,25 1,35 GHz?PM0,1 200 W/m2Occupational exposureLymphocytes (Human), in vivopos.Fucic et al. 19927,7 GHzcw5 W/m215 - 60 minFibroblasts (Chin. Hamster), in vitropos., s.s.Garaj-Vrohac et al. 19917,7 GHzcw5 300 W/m210 minLymphocytes (Human), in vitropos., s.s.Garaj-Vrohac et al. 19922,45 GHzcw75 W/kg30 120 minLymphocytes (Human), in vitropos.Maes et al. 19939,0 GHzcw70 W/kg10 minLymphocytes (bovine), in vitropos., s.s.Scarfi et al. 19962,45cw50 W/m2 12,46 W/kg90 minLymphocytes (Human), in vitropos.#, n.s.Vijayalaxmi et al. 1997 b2,45cw1,0 W/kg18 monErythroczyten (Mouse blood / bone marrow)pos, s.s.Vijayalaxmi et al. 1997 aSister chromatid exchange380 MHzPM, 17,65 Hz80 W/kg?Lymphocytes (Human), in vitroneg.Antonopoulos et al. 1997900 MHzPM/DCS, 217 Hz208 W/kg?Lymphocytes (Human), in vitroneg.Antonopoulos et al. 19971,8 GHzPM/GSM, 217 Hz1700 W/kg?Lymphocytes (Human), in vitroneg.Antonopoulos et al. 19972,45 GHzcw??Mouse (bone marrow), in vivoneg.Banerjee et al. 19832,45 GHzPM, 25 kHz490 W/m2 33,8 W/kg2 hEgg Cells (Chinese Hamster), in vitroneg.Ciaravino et al. 19872,45 GHzPM, 25 kHz490 W/m2 33,8 W/kg2 hEgg Cells (Chinese Hamster), in vitroneg.Ciaravino et al. 19912,45 GHzcw104 193 W/kg20 minLymphocytes (Human), in vitro, Add. caffeinepos., s.s.#Lloyd et al. 19842,45 GHzcw75 W/kg30 120 minLymphocytes (Human), in vitroneg.Maes et al. 1993954 MHzPM/GSM, 217 Hz1,5 W/kg2 hLymphocytes (Human), in vitropos., s.s.Maes et al. 1996935,2 MHzPM/GSM, 217 Hz0,3 0,4 W/kg2 hLymphocytes (Human), in vitropos., partly s.s.Maes et al. 19972,45 GHzcw100 W/m2120 d 6 h/dSpermatogonia (Mouse), in vivoneg.Saunders et al. 1988Mutations2,45 GHzAM, 100 Hz40 80 W/kg2 h 6 hEscherichia coli, in vitropartly pos., s.s.Anderstam et al. 19832,45 GHzAM, 100 Hz40 80 W/kg4 h 7 hSalmonella typhimurium, in vitroneg.Anderstam et al. 19833,07 GHzPM, 500 Hz95 W/kg1 hEscherichia coli, in vitroneg.Anderstam et al. 19833,07 GHzPM, 500 Hz75 - 100 W/kg2 h 2,5 hSalmonella typhimurium, in vitroneg.Anderstam et al. 19839,4 GHzcw600 W/m2 23 W/kg30 120 minEscherichia coli, in vitroneg.Dardalhon et al. 19819,4 GHzcw600 W/m2 23 W/kg30 120 minSaccharomyces cerevisiae, in vitropartly pos., s.s.Dardalhon et al. 19819,4 GHzcw10 600 W/m2330 minSaccharomyces cerevisiae, in vitropos.Dardalhon et al. 19852,45 GHzAM, 100 Hz130 W/kg5,7 hSalmonella typhimurium, in vitropartly pos, s.s.Hamnerius et al. 19853,10 GHzPM, 500 Hz90 W/kg6 hSalmonella typhimurium, in vitropartly pos., n.s.Hamnerius et al. 19852,45 GHzAM, 100 Hz110 W/kg6 hDrosophila melanogaster, in vivoneg.Hamnerius et al. 19853,10 GHzPM, 500 Hz60 W/kg6 hDrosophila melanogaster, in vivoneg.Hamnerius et al. 19852,375 MHzcw150.000 250.000 W/m225 300 minDrosophila melanogaster, in vivopartly pos., s.s.Marec et al. 19852,45PM, 25 kHz480 W/m2 30 W/kgbis 63 hLeukaemia-Cells (Mouse), in vitropos./neg., partly s.s.Meltz et al. 19892,45 GHzPM, 25 kHz650 870 W/m2 40 40,8 W/kg4 hLeukaemia-Cells (Mouse), in vitroneg.Meltz et al. 1990 Table A.2 Effects of High Frequency Electromagnetic Fields on Cellular Processes Frequency ModulationPower Flux Density SARExposure DurationExamines Subject MethodResultRef.Gene transcription and gene translation890 915 GHzPM/GSM, 217 Hz0,3 7,5 W/kg4 hBrain (Rat), in vivopos., partly s.s.Fritze et al. 1997 a835,62 MHzFM/cw0,6 W/kg4 dFibroblasts (Mouse), in vitropartly pos., s.s.Goswami et al. 1999847,74 MHzPM/CDMA, 50 Hz0,6 W/kg4 dFibroblasts (Mouse), in vitropartly pos., s.s.Goswami et al. 1999836,55 MHzPM/TDMA, 50 Hz0,9 90 W/m2 0,00026 0,026 W/kg20 100 minPheochromocytoma Cells (Rat), in vitropos., s.s.Ivaschuk et al. 1997Cell-Cycle380 MHzPM, 17,65 Hz80 W/kg?Lymphocytes (Human), in vitroneg.Antonopoulos et al. 1997900 MHzPM/DCS, 217 Hz208 W/kg?Lymphocytes (Human), in vitroneg.Antonopoulos et al. 19971,8 GHzPM/GSM, 217 Hz1700 W/kg?Lymphocytes (Human), in vitroneg.Antonopoulos et al. 19972,45 GHzPM, 25 kHz490 W/m2 33,8 W/kg2 hEgg Cells (Chinese Hamster), in vitroneg.Ciaravino et al. 19912,45 GHzcw5 25 W/kg2 hEgg Cells (Chinese Hamster), in vitropos., s.s.Cleary et al. 19969,4 GHzPM, 1,0 kHz1 100 W/m22 w 5 d/w 1 h/dMouse, in vivopos., s.s.Manikowska et al. 19792,45 GHzcw100 W/m26x1 hLymphocytes (Human), in vitroneg.Pazmany et al. 19902,45 GHzcw100 W/m23x1 hLymphocytes (Human), in vitroneg.Pazmany et al. 19902,45 GHzcw100 W/m25 hLymphocytes (Human), in vitropos., s.s.Pazmany et al. 1990 Table A.3 Effects of High Frequency Electromagnetic Fields on Cell Transformation and Cell Proliferation Frequency ModulationPower Flux Density SARExposure DurationStudied Subject MethodResultRef.Cell Transformations (including neoplastic)2,45 GHzPM, 120 Hz4,4 W/kg24 hFibroblasts (Mouse), in vitropartly pos., s.s.Balcer-Kubiczek & Harrison 19852,45 GHzPM, 120 Hz4,4 W/kg24 hFibroblasts (Mouse), in vitropartly pos., s.s.Balcer-Kubiczek & Harrison 19892,45 GHzPM, 120 Hz0,1 4,4 W/kg24 hFibroblasts (Mouse), in vitropartly pos., s.s.Balcer-Kubiczek & Harrison 19912,45 GHzcw0,8 12,3 W/kg5 dLymphocytes (Human), in vitroneg.Czerska et al. 19922,45 GHzPM, 1000 Hz0,8 12,3 W/kg5 dLymphocytes (Human), in vitropos., s.s.Czerska et al. 19922,45 GHzcw50 W/m2Lymphocytes (Mouse)pos.Smialowicz et al. 1979Cell Communication836,55 MHzPM, TDMA, 50 Hz0,3 30 W/m2 0,00015 - 0,015 W/kg28 dFibroblasts (Mouse), in vitropartly pos., s.s.Cain et al. 1997Cell Proliferation2,45 GHzAM, 100 Hz40 80 W/kg2 h 6 hEscherichia coli, in vitropartly pos., s.s.Anderstam et al. 19832,45 GHzAM, 100 Hz40 80 W/kg4 h 7 hSalmonella typhimurium, in vitropartly pos., s.s.Anderstam et al. 19833,07 GHzPM, 500 Hz95 W/kg1 hEscherichia coli, in vitropartly pos., s.s.Anderstam et al. 19833,07 GHzPM, 500 Hz75 - 100 W/kg2 h 2,5 hSalmonella typhimurium, in vitropartly pos., s.s.Anderstam et al. 1983900 MHzPM/GSM, 217 Hz0,55 2,0 W/m2 0,075 0,270 W/kg10 d 2 h/dLymphocytes (Rat, (Sprague-Dawley), in vivoneg.Chagnaud & Veyret 19992,45cw5 50 W/kg2 hBlut (Human), Lymphocytes, in vitropos., s.s.Cleary et al. 1990 a2,45cw5 75 W/kg2 hGlioma-Cells, in vitropos. s.s.Cleary et al. 1990 b2,45 GHzcw5 50 W/kg2 hT-Lymphocytes (Mouse, CTLL-2), in vitropos., s.s.Cleary et al. 19962,45 GHzPM/PCS, 50 Hz5 W/kg2 hT-Lymphocytes (Mouse, CTLL-2), in vitropos., s.s.Cleary et al. 19962,45 GHz??15 s 5 hMyeloma- and Hybridoma-Cells (Mouse), in vitro?, Methode fragwrdigDorp et al. 1998150 MHzAM, 72 Hz, 217 Hz, 1100 Hz1,6 kV/m 5,4 TEscherichia coli, in vitropos., partly s.s.Grospietsch et al. 19952,45 GHzAM, 100 Hz130 W/kg5,7 hSalmonella typhimurium, pos, s.s.Hamnerius et al. 19853,10 GHzPM, 500 Hz90 W/kg6 hSalmonella typhimurium, pos., s.s.Hamnerius et al. 1985836,55 MHzPM, TDMA, 50 Hz0,9 90 W/m2 0,00015 - 0,059 W/kg4 h 14 dGlioma-Cells (Rat), in vitroneg.Stagg et al. 1997960 MHzPM, GSM, 217 Hz0,0021 W/kg30 mintransform. Epithel-Amnion-Cells (Human), in vitropos., (s.s)Velizarov et al. 1999 Appendix B Studies of the Effects of High Frequency Electromagnetic Fields on the Central Nervous System (Blood-Brain-Barrier) Abbreviations neg. negative finding n.s. not statistically significant pos. positive finding s.s. statistically significant partly some findings # disagreement with the conclusions of the authors ? unknown; not provided; unreliable Table B.1 Effects of High Frequency Electromagnetic Fields on the Central Nervous System Frequency ModulationPower Flux Density / SARExposure durationStudies subject / MethodResultRef.2,8 GHzcw100 W/m22 hRat (Wistar)pos.Albert 19792,45 GHzcw100 W/m2 2,5 W/kg2 hHamster (Chin.)pos., s.s.Albert & Kerns 1981900 MHzPM/GSM, 217 Hz0,3 7,5 W/kg4 hRat (Wistar)pos., partly s.s.Fritze et al. 1997 b2,8 GHzcw100 400 W/m24 hRat (Tac:N(SD)sBR)partly pos, n.s.Gruenau et al. 19822,8 GHzPM, 500 Hz10 150 W/m24 hRat (Tac:N(SD)sBR)partly pos, n.s.Gruenau et al. 19822,45 GHzPM, 100 Hz100 W/m2 2 W/kg30 min 2 hRat (Sprague Dawley)pos., s.s.Neubauer et al. 19901,3 GHzcw3 30 W/m220 minRat (Wistar)pos., s.s.Oscar & Hawkins 19771,3 GHzPM, 5 Hz0,3 0,5 W/m220 minRat (Wistar)pos., s.s.Oscar & Hawkins 19771,3 GHzPM, 1000 Hz1 10 W/m220 minRat (Wistar)pos., s.s.Oscar & Hawkins 19772,45 GHzcw1,0 300 W/m230 minRat (Sprague-Dawley)partly pos., s.s.Preston et al. 1979915 MHzcw0,3 5,0 W/kg2 hRat (Fischer 344)pos., s.s.Salford et al. 1994915 MHzPM, 8 Hz0,016 0,16 W/kg2 hRat (Fischer 344)pos., s.s.Salford et al. 1994915 MHzPM, 16 Hz0,03 2,1 W/kg2 hRat (Fischer 344)pos., s.s.Salford et al. 1994915 MHzPM, 50 Hz0,3 5,0 W/kg2 hRat (Fischer 344)pos., s.s.Salford et al. 1994915 MHzPM, 200 Hz0,4 2,9 W/kg2 hRat (Fischer 344)pos., s.s.Salford et al. 1994 Appendix C Studies of the Carcenogenic Effects of High Frequency Electromagnetic Fields in Animal Experiments Abbreviations neg. negative finding n.s. not statistically significant pos. positive finding s.s. statistically significant partly some findings # disagreement with the conclusions of the authors ? unknown; not provided; unreliable Table C.1 Animal Experiments regarding the Carcenogenic Effects of High Frequency Electromagnetic Fields Frequency ModulationPower Flux Density / SARExposure durationStudies subject / MethodResultRef.836,55 MHzPM/TDMA, 50 Hz0,74 1,6 W/kg24 mon 4 d/w 2 h/dRat (Fischer 344)neg.Adey et al. 1999900 MHzPM/GSM, 217 Hz0,55 2,0 W/m22 w, 2 h/dRat, Cancer, totalneg.Chagnaud et al. 19992,45 GHzPM, 800 Hz0,15 0,425 monRat, Cancer, totalpos., s.s.Chou et al. 19922,45 GHzcw0,3 W/kg18 mon, 7 d/w, 20 h/dMouse (C3H/HeJ), Cancer, totalneg.Frei et al. 1998 a2,45 GHzcw1,0 W/kg78 w, 7 d/w, 20 h/dMouse (C3H/HeJ), Cancer, totalpartly pos., n.s.Frei et al. 1998 b835,62 MHzFM, cw0,75 W/kg150 d, 5 d/w, 4 h/dRat (Fischer 344), B16 Melanomapartly pos., n.s.Higashikubo et al. 1999835,62 MHzPM/CDMA, 50 Hz0,75 W/kg150 d, 5 d/w, 4 h/dRat (Fischer 344), B16 Melanomaneg.Higashikubo et al. 1999929,2 MHzPM/TDMA, 50 Hz0,58 0,86 w, 5 d/w, 90 min/dRat (Fischer 344), Liver cancerneg.Imaida et al 1998 a1,439 GHzPM/TDMA, 50 Hz0,453 - 0,680 W/kg6 w, 5 d/w, 90 min/dRat (Fischer 344), Liver cancerneg.Imaida et al. 1998 b900 MHzPM/GSM, 217 Hz2,6 13 W/m2 0,008 4,2 W/kg18 mon 30 min/dMouse (transgenic E-Pim1), Lyphomaspos., s.s.Repacholi et al. 1997915 MHzPM, 4 217 Hz0,0077 1,0 W/kg2-3 w 5d/w 7h/dRat (Fischer 344), Brain Tumorpartly pos., n.s.Salford et al. 19932,45 GHzcw10 W/m2 1,2 W/kgmax. 46 w, 6 d/w, 2,5 h/dMouse (C57BL/6J), B16 Melanomapartly pos., n.s.Santini et al. 19882,45 GHzPM, 25 Hz10 W/m2 1,2 W/kgmax. 46 w, 6 d/w, 2,5 h/dMouse (C57BL/6J), B16 Melanomapartly pos., n.s.Santini et al. 19882,45 GHzcw50 150 W/m2 2 8 W/kg12 mon 6d/w, 2h/dMouse (C3H/HeA), Cancer, totalpos., s.s.Szmigielski et al. 19822,45 GHzcw50 150 W/m2 2 8 W/kg5 mon 6d/w, 2h/dMouse (Balb/c), Skin Cancerpos., s.s.Szmigielski et al. 19822,45 GHzcw50 150 W/m26 mon, 2 h/dMouse (Balb/c), Hautcancerpos., s.s.Szudinski et al. 1982435 MHzPM, 1,0 kHz10 W/m2 0,32 W/kg21 monMouse (C3H/HeJ), Chest tumors, Ovarian tumorspartly pos., s.s.Toler et al. 19972,45 GHzcw100 W/m2 11 W/kg5 mon, 6 d/w, 3 h/dMouse (Balb/c), Intestinal cancerpartly pos., n.s.Wu et al. 1994 Appendix D Epidemiological Studies of the Health Risks of High Frequency Electromagnetic Fields Table D.1 Overview of the Results of Epidemiological Studies regarding Exposures in the High Frequency Spectrum and Health Risks Column 1: Studied illness Column 2: Exposure situation Column 3: Reliability of the exposure classification: 3: Source of exposure and quantity clearly identified, 2: Method of exposure clearly identified 1: HF-exposure probable Column 4: Relative Risk (R.R.), Explanations see text Column 5: Statistical significance of the findings: s.s.: statistically significant(R.R.=1 outside of 95 %-trust interval, or. p<0,05 n.s.: statistically not significant Column 6: Literatur reference Column 7: Comments: R: Values in the Column R.R. obtained by conversion (reciprocal value, proportion) of other numerical values or via the interpretation of diagrams *: Paper listed in the literature references of Appendix E IllnessExposureExp. class.R.R.stat. Sign.ReferencesCAll IllnessesAll illnesses, morbidityMW, Radar, Military21,18n.s.Robinette et al. 1980R*All Illnesses, morbidityMW, mobile telecommunications30,93n.s.Rothman et al. 1996Cancer, totalCancer, total, morbidityMW, Radar, Military21,50n.s.Robinette et al 1980R*Cancer, total, IncidenceRF, Radio, women21,2s.s.Tynes et al. 1996*Cancer, total, IncidenceRF/MW, Military22,07s.s.Szmigielski 1996*Cancer, total, IncidenceHF, Radio and TV transmitters, local residents31,09s.s.Dolk et al. 1997 a*Cancer, total, IncidenceHF, place of work12,0n.s.Lagorio et al. 1997Cancer, total, IncidenceRF/MW, Radar and Radio, Police20,96n.s.Finkelstein 1998*Multiple MyelomeHF, Radio and TV transmitters, local residents31,23n.s.Dolk et al. 1997 a*Brain tumors, total and tumors of the nervous system, totalBrain-Tumors, total, MorbidityHF, Place of work11,54n.s.Lin et al. 1985Brain-Tumors, Glioblastomas and Astrocytoma, MorbidityHF, Place of work12,15s.s.Lin et al. 1985Brain-Tumors, total, MorbidityHF, Place of work, Men10,38n.s.Milham 1985Brain-Tumors, total, MorbidityRF/MW, Place of work, Men22,3s.s.Thomas et al. 1987*Brain-Tumors, total, MorbidityRF, Amateur Radio Users21,39n.s.Milham 1988Brain-Tumors, total, IncidenceHF, Place of work12,9s.s.Trnqvist et al. 1991Brain-Tumors, Glioblastomas, IncidenceHF, Place of work13,4s.s.Trnqvist et al. 1991Brain-Tumors, total, IncidenceRF, Place of work, Men20,61n.s.Tynes et al. 1992Brain-Tumors, total, IncidenceRF, Radio, Women21,0Tynes et al. 1996*Brain-Tumors, total, IncidenceHF, Place of work, Men12,4s.s.Beall et al. 1996Brain-Tumors, total, IncidenceRF/MW, Military21,39s.s.Grayson 1996*Brain-Tumors, total, MorbidityHF/MW, TV transmitters and others residents (adults)30,89n.s.Hocking et al. 1996*Brain-Tumors, total, IncidenceHF/MW, TV and other transmitters, Local residents/ Adults30,82n.s.Hocking et al. 1996*Brain-Tumors, total, MorbidityHF/MW, TV and other transmitters, Local residents/child.31,0Hocking et al. 1996*Brain-Tumors, total, IncidenceHF/MW, TV and other transmitters, Local residents/child.31,3n.s.Hocking et al. 1996*Tumors des Nervensystems einschl. Hirntumors, IncidenceRF/MW, Military21,91s.s.Szmigielski 1996*Brain-Tumors, total, IncidenceHF, Radio and TV transmitters, Local residents31,29n.s.Dolk et al. 1997 a*Brain-Tumors, maligne, IncidenceHF, Radio and TV transmitters, Local residents31,31n.s.Dolk et al. 1997 a*Brain-Tumors, total, IncidenceRF/MW, Radar and Radio, Police20,84n.s.Finkelstein 1998*Brain-Tumors, total, IncidenceMW, Mobil telecommunications, Mobile phones31,20n.s.Hardell et al. 1999*Brain-Tumors, Expos.seite, IncidenceMW, Mobilradio, Handy3R 2,45 L 2,40n.s. n.s.Hardell et al. 1999*Cancer, EyesMelanome, Augen, IncidenceMW, Radar, Military12,1s.s.Holly et al. 1995Cancer of the respiratory system, lung cancerCancer der Atmungsorgane, MorbidityMW, Radar, Military22,59s.s.Robinette et al. 1980R*Lungencancer, MorbidityHF, Place of work, Men10,80n.s.Milham 1985Lungencancer, IncidenceRF, Radio, Women21,2n.s.Tynes et al. 1996*Lungencancer, IncidenceHF, Radio and TV transmitter, Local residents31,01n.s.Dolk et al. 1997 a*Lungencancer, IncidenceRF/MW, Radar and Radio, Police20,66s.s.Finkelstein 1998*Chest cancer, MenBrustcancer, Mnner, IncidenceHF, Place of work12,9n.s.Demers et al. 1991Brustcancer, Men, IncidenceHF, Radio and TV transmitters, Local residents31,64n.s.Dolk et al. 1997 a*Breast cancer, WomenBrustcancer, Women, MorbidityHF, Place of work21,15s.s.Cantor et al. 1995*Brustcancer, Women, IncidenceRF, Radio, Women21,5s.s.Tynes et al. 1996*Brustcancer, Women, IncidenceHF, Radio adn TV transmitters, Local residents31,08n.s.Dolk et al. 1997 a*Cancer of the lymphatic and blood forming systems, totalCancer des lymphat. and des blutbild. Systems, MorbidityMW, Radar, Military21,98n.s.Robinette et al. 1980R*Cancer des lymphat. and des blutbild. Systems, MorbidityHF, Place of work, Men11,37n.s.Milham 1985Cancer des lymphat. and des blutbild. Systems, IncidenceHF, Radio and TV transmitters, Local residents31,21n.s.Dolk et al. 1997 a*Cancer des lymphat. and des blutbild. Systems, IncidenceRF/MW, Military26,31s.s.Szmigielski 1996*Leukaemia, totalLeukaemia, total, MorbidityHF, Place of work11,11n.s.Milham 1982Leukaemia, total, MorbidityRF, Amateur radio user21,91s.s.Milham 1985 aLeukaemia, total, MorbidityHF, Place of work, Men11,02n.s.Milham 1985 bLeukaemia, total, MorbidityRF Amateur radio user21,24n.s.Milham 1988Leukaemia, total, IncidenceHF, Military12,4s.s.Garland et al. 1990Leukaemia, total, IncidenceHF, Place of work10,8n.s.Trnqvist et al. 1991Leukaemia, total, IncidenceRF, Place of work, Men22,85s.s.Tynes et al. 1992Leukaemia, total, IncidenceRF, Radio, Women21,1n.s.Tynes et al. 1996*Leukaemia, total, MorbidityRF/MW, TV and other transmitters, Local residents/ Adults31,17n.s.Hocking et al. 1996*Leukaemia, total, MorbidityRF/MW, TV and other transmitters, Local residents/ children.32,32s.s.Hocking et al. 1996*Leukaemia, total, IncidenceRF/MW, TV and other transmitters , Local residents/ Adults31,24s.s.Hocking et al. 1996*Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents/ Children.31,58s.s.Hocking et al. 1996*Leukaemia, total, IncidenceHF, Radio and TV transmitters, Local residents31,83s.s.Dolk et al. 1997 a*Leukaemia and Non-Hodgkin-Lymphoma, total, IncidenceHF, Radio and TV transmitters, Local residents31,25n.s.Dolk et al. 1997 a*Leukaemia, total, IncidenceRF/MW, Radar and Radio, Police20,6n.s.Finkelstein 1998*Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents/ children.31,47n.s.McKenzie et al. 1998*Acute Leukaemia, totalAcute Leukaemia, total, MorbidityHF, Place of work12,39n.s.Milham 1982Acute Leukaemia, total, MorbidityHF, Place of work, Men12,12n.s.Milham 1985Acute Unspez. Leukaemia, MorbidityRF, Amateur radio users21,76n.s.Milham 1988Acute Leukaemia, total, IncidenceHF, TV and Radio transmitters, Local residents31,86n.s.Dolk et al. 1997 a*Lymphat. Leukaemia, totalLymphat. Leukaemia, total, MorbidityRF, Amateur radio users20,77n.s.Milham 1985Lymphat. Leukaemia, total, MorbidityRF, Amateur radio users21,03n.s.Milham 1988Lymphat. Leukaemia, total, MorbidityRF/MW, TV and other transmitters, Local residents/ Adults31,39s.s.Hocking et al. 1996*Lymphat. Leukaemia, total, MorbidityRF/MW, TV and other transmitters, Local residents/ children.32,74s.s.Hocking et al. 1996*Lymphat. Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents/ Adults31,32s.s.Hocking et al. 1996*Lymphat. Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents/ children31,55s.s.Hocking et al. 1996*Lymphat. Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents /children.31,53n.s.McKenzie et al. 1998*Acute Lymphat. LeukaemiaAcute Lymphat. Leukaemia, MorbidityRF, Amateur radio users21,20n.s.Milham 1988Acute Lymphat. Leukaemia, IncidenceHF, Radio and TV transmitters, Local residents33,57n.s.Dolk et al. 1997 a*Chron. Lymphat. LeukaemiaChron. Lymphat. Leukaemia, MorbidityRF, Amateur radio users21,43n.s.Milham 1985Chron. Lymphat. Leukaemia, MorbidityRF, Amateur radio users21,09n.s.Milham 1988Chron. Lymphat. Leukaemia, IncidenceHF, Place of work11,3n.s.Trnqvist et al. 1991Chron. Lymphat. Leukaemia, IncidenceHF, Radio and TV transmitters, Local residents32,56s.s.Dolk et al. 1997 a*Myelo. Leukaemia, totalMyelo. Leukaemia, total, Morbidity RF, Amateur radio users22,81s.s.Milham 1985Myelo. Leukaemia, total, MorbidityRF, Amateur radio users21,40n.s.Milham 1988Myelo. Leukaemia, total, MorbidityRF/MW, TV and other transmitters, Local residents/ Adults31,01n.s.Hocking et al. 1996*Myelo. Leukaemia, total, MorbidityRF/MW, TV and other transmitters, Local residents/child.31,77n.s.Hocking et al. 1996*Myelo. Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents/ Adults31,09n.s.Hocking et al. 1996*Myelo. Leukaemia, total, IncidenceRF/MW, TV and other transmitters, Local residents/child.31,73n.s.Hocking et al. 1996*Acute Myelo. LeukaemiaAcute Myelo. Leukaemia, MorbidityRF, Amateur radio users22,89s.s.Milham 1985Acute Myelo. Leukaemia, MorbidityRF, Amateur radio users21,76s.s.Milham 1988Acute Myelo. Leukaemia, IncidenceHF, Place of work12,1n.s.Trnqvist et al. 1991Acute Myelo. Leukaemia, IncidenceHF, Radio, TV, Local residents31,02n.s.Dolk et al. 1997*Chron. Myelo. LeukaemiaChron. Myelo. Leukaemia, MorbidityRF, Amateur radio users22,67s.s.Milham 1985Chron. Myelo. Leukaemia, MorbidityRF, Amateur radio users20,86Milham 1988Chron. Myelo. Leukaemia, IncidenceHF, Radio and TV transmitters, Local residents31,23n.s.Dolk et al. 1997*Leukaemia, non-lymph. and non-myelo.Leukaemia, non-lymph. and non-myelo., MorbidityRF/MW, TV and other transmitters, Local residents/ Adults31,57s.s.Hocking et al. 1996*Leukaemia, non-lymph. and non-myelo., MorbidityRF/MW, TV and other transmitters, Local residents/child.31,45n.s.Hocking et al. 1996*Leukaemia, non-lymph. and non-myelo., IncidenceRF/MW, TV and other transmitters, Local residents/ Adults31,67s.s.Hocking et al. 1996*Leukaemia, non-lymph. and non-myelo., IncidenceRF/MW, TV and other transmitters, Local residents/child.31,65n.s.Hocking et al. 1996*Lymphomas, Hodgkin-SyndromeLymphosarkome, MorbidityHF, Place of work, Men10,73n.s.Milham 1985Lymphome, excl. Lymphosarkoma, MorbidityHF, Place of work, Men13,42n.s.Milham 1985Hodgkin-Syndrome, MorbidityRF, Amateur radio users21,23n.s.Milham 1988Other malignant illness of the lymphat. tissues, MorbidityRF, Amateur radio users21,62s.s.Milham 1988Lymphomas, total, IncidenceRF, Radio, Women21,3n.s.Tynes et al. 1996*Hodgkin-Syndrome, IncidenceRF/MW, Radar and Radio, Police20,84n.s.Finkelstein 1998*Non-Hodgkin-Lymphoma, IncidenceHF, Radio and TV transmitters, Local residents30,66n.s.Dolk et al. 1997 a*Testicular cancerTesticular cancer, IncidenceRF/MW, Place of work23,1s.s.Hayes et al. 1990Germ cell-Carcinoma, SeminomaRF/MW, Place of work22,8n.s.Hayes et al. 1990Germ cell-Carzinome, othersRF/MW, Place of work23,2s.s.Hayes et al. 1990Testicular cancer, IncidenceMW, Radar, Police26,9s.s.Davis & Mostofi 1993*Testicular cancer, IncidenceRF/MW, Radar and Radio, Police21,33s.s.Finkelstein 1998*Cancer of the uterusCancer of the uterus, IncidenceRF, Radio, Women21,9s.s.Tynes et al. 1996*Skin cancerSkin Cancer, Malignant Melanoma, IncidenceRF, Radio, Women20,9n.s.Tynes et al. 1996*Skin Cancer, total, IncidenceRF/MW, Military21,67n.s.Szmigielski 1996*Skin cancer, Malignant Melanoma, IncidenceHF, Radio and TV transmitters, Local residents31,43n.s.Dolk et al. 1997 a*Skin cancer, Malignant Melanoma, IncidenceRF/MW, Radar and Radio, Police21,37s.s.Finkelstein 1998*Heart and cardio vascular diseasesCardio vascular diseases, MorbidityMW, Radar, Military21,09n.s.Robinette et al. 1980R*Cardio vascular diseases, MorbidityRF, Amateur radio users20,70s.s.Milham 1988Abnorm. Hearbeat rate variabilityRF/AM, Radio transmitters, Place of work21,6s.s.Bortkiewicz et al. 1996*Abnormal ECGMW22,9?Zhao et al. 1994RCardio vascular complaintsMW23,2?Zhao et al. 1994RInfertility, reduced fertility, Menreduced Fertility, reduced Sperm countMW, Place of work21,20s.s.Lancranjan et al. 1975Rreduced Fertility, immob. SpermatozoaMW, Place of work21,39s.s.Lancranjan et al. 1975Rreduced Fertility, normal SpermatozoaMW, Place of work21,18s.s.Lancranjan et al. 1975Rreduced. Fertility, reduced Sperm countMW, Military22,70s.s.Weyandt et al. 1996Rreduced Fertility, reduced sperm countMW, Radar21,54n.s.Hjollund et al. 1997Rreduced Fertility, immob. SpermatozoaMW, Radar21,58n.s.Hjollund et al. 1997Rreduced Fertility, reduced Sperm countMW, Radar21,10n.s.Schrader et al 1998RInfertility, reduced. fertility, Womenreduced. fertilitytKW, Place of work, Physiotherapie, Mothers21,7n.s.Larsen et al. 1991 a*Miscarriages, Stillbirths, Malformations and other abnormalities of newbornsMalformations and perinatal deathKW, Place of work, Mother22,36s.s.Klln et al 1982MiscarriageMW, Place of work, Mother21,28s.s.Ouellet-Hellstrom & Stewart 1993*MiscarriageKW, Place of work, Mother21,07n.s.Ouellet-Hellstrom & Stewart 1993*Cancer, Offspring (parental exposure)Tumors of the nervous systemHF, Place of work, fathers12,01n.s.Cole Johnson & Spitz 1989Cancer, total, IncidenceRadar, Place of work, fathers22,3s.s.Smulevich et al. 1999*Neurodegenerative DiseasesAlzheimers, MorbidityHF, Place of work11,5n.s.Savitz et al. 1998*Parkinsons DiseaseHF, Place of work1-Savitz et al. 1998*Amyotrophic Lateral SklerosisHF, Place of work1-Savitz et al. 1998*Disturbances of motoric and psychological reactions, UnwellnessReduced stamina, BoysMW, Radar21,38s.s.Kolodynski & Kolodynska 1996R*Reduced stamina, GirlsMW, Radar21,38s.s.Kolodynski & Kolodynska 1996R*reduced memory, BoysMW, Radar21,09s.sKolodynski & Kolodynska 1996R*Reduced memory, GirlsMW, Radar21,12s.sKolodynski & Kolodynska 1996R*Reduced concentration, BoysMW, Radar21,23s.s.Kolodynski & Kolodynska 1996R*Reduced Concentration, GirlsMW, Radar21,20s.s.Kolodynski & Kolodynska 1996R*Extended reaction time, BoysMW, Radar21,07n.s.Kolodynski & Kolodynska 1996R*Extended reaction time, GirlsMW, Radar21,12s.s.Kolodynski & Kolodynska 1996R*Unwellness. ('Neurosis')MW23,2?Zhao et al. 1994R Appendix E (not available in translation) Extracts of our Database (EMFbase) Important research papers relevant to the assessment of health risks resulting from exposure to the electromagnetic fields of mobile telecommunications under the aspect of precautionary health protection c&';HSn,-.;HSn+E. J _ x    @ b ʿʿʿʿʿῪNHOJQJ^JmH sH H*OJQJ^JOJQJ^JmH sH OJQJ^JmHsHH*OJQJ^JmH sH  OJQJ^JOJQJ^JmH sH CJOJQJ^JmH sH C  bcdest*N$If^z5L/$If$$IfF4֞'08       04 Fa(7;HSdX$Ifa$$IfF48[8   04 Fa deny6x0000$If$$IfF֞'08       04 Fa0<$$IfF֞'08       04 Fa$If$If&.76L0000$If$$IfF֞'08       04 Fa7;HSde0L$$IfF֞'08       04 Fa$Ifeny$If60000$If$$IfF֞'08       04 Fa (0$$IfF֞'08       04 Fa$If(+:Eci~$If~60000$If$$IfF֞'08       04 Fa0t$$IfF֞'08       04 Fa$If  . 4 I $IfI J S V _ c 60000$If$$IfF֞'08       04 Fac x z 0$$IfF֞'08       04 Fa$If  $If     $ 60000$If$$IfF֞'08       04 Fa$ @ b m 0L$$IfF֞'08       04 Fa$If $If 60$If$$IfF֞'08       04 Fa    & 0 N c u $Ifa$$IfF48[8   04 Fa     Z [ 0Xu UVc=]qxy %>Yq-AGHRt +E]OJQJ^JmH sH OJQJ^JmHsHH*OJQJ^JmH sH OJQJ^JmH sH H*OJQJ^J OJQJ^JMu v ~ 60000$If$$IfF֞'08       04 Fa 0$$IfF֞'08       04 Fa$If    9 N ` $If` a i t 60000$If$$IfF֞'08       04 Fa 0$$IfF֞'08       04 Fa$If  ( : $If: ; C N \ f 60000$If$$IfF֞'08       04 Faf 0$$IfF֞'08       04 Fa$If /$If/0G6`0$If$$IfF֞'08       04 FaGHQTVXuz $Ifa$$IfF48[8   04 Fa6(0000$If$$IfF֞'08       04 Fa0$$IfF֞'08       04 Fa$If +D$IfDEMPWc60000$If$$IfF֞'08       04 Fac0$$IfF֞'08       04 Fa$If$If!,-.640000$If$$IfF֞'08       04 Fa.=I\]f0$$IfF֞'08       04 Fa$Iffqz$If6`0000$If$$IfF֞'08       04 Fa $%.00$$IfF֞'08       04 Fa$If.1>EY^p$Ifpqz}6X0000$If$$IfF֞'08       04 Fa0$$IfF֞'08       04 Fa$If,-5B$$IfF4ֈ'08     04 Fa$If5AIRVt$If60000$If$$IfF֞'08       04 Fa0$$IfF֞'08       04 Fa$If +:E\$If\]fix60000$If$$IfF֞'08       04 Fa0@$$IfF֞'08       04 Fa$If$If&)1@6h0000$If$$IfF֞'08       04 Fa1NYq4GH9T"4\mno9:`ABNsY7Gd̸̸H*OJQJ^JH*OJQJ^JmH sH  OJQJ^JH*OJQJ^JmH sH OJQJ^JmH sH OJQJ^JmH sH OJQJ^JmHsHH@NYpqz0l$$IfF֞'08       04 Fa$Ifz}$If60000$If$$IfF֞'08       04 Fa340$$IfF֞'08       04 Fa$If4=@IT$If6d0000$If$$IfF֞'08       04 Fa04$$IfF֞'08       04 Fa$If 9T_k$Ifa$$IfF48[8   04 FakluxHBBBBBB$If$$IfF4ֈ'08     04 Fa0$$IfF֞'08       04 Fa$If"4K$IfKL\`o60000$If$$IfF֞'08       04 Fa0$$IfF֞'08       04 Fa$If "$If"#+.;B60000$If$$IfF֞'08       04 FaB`k0X$$IfF֞'08       04 Fa$If$If6`0000$If$$IfF֞'08       04 Fa2380$$IfF֞'08       04 Fa$If8;CNUs$If60000$If$$IfF֞'08       04 Fa0l$$IfF֞'08       04 Fa$If$19;Y^wp$Ifa$$IfF48[8   04 Fawx6|0000$If$$IfF֞'08       04 Fa0$$IfF֞'08       04 Fa$If6$If67@CEG6 0000$If$$IfF֞'08       04 FaGdi~0$$IfF֞'08       04 Fa$If$If*Yt{4A_/Edz:Fa , P Z [ d !!1!L!M!\!]!!!!!!!!NHOJQJ^JmH sH OJQJ^JmH sH H*OJQJ^JmH sH OJQJ^JmHsHOJQJ^JmH sH  OJQJ^JH*OJQJ^JH 60000$If$$IfF֞'08       04 Fa=BXY0$$IfF֞'08       04 Fa$IfYbet{$If6X0000$If$$IfF֞'08       04 Fa %0|$$IfF֞'08       04 Fa$If%4=A_j{$If{|60000$If$$IfF֞'08       04 Fa0l$$IfF֞'08       04 Fa$If */D$IfDEO6,0$If$$IfF֞'08       04 FaOPYdqz$Ifa$$IfF48[8   04 Fa60000$If$$IfF֞'08       04 Fa %&/0\$$IfF֞'08       04 Fa$If/:BFaf|$If|}60000$If$$IfF֞'08       04 Fa0$$IfF֞'08       04 Fa$If  , 1 G $IfG H P S \ d 60000$If$$IfF֞'08       04 Fad q 0$$IfF֞'08       04 Fa$If !!!$If!!&!1!:!@!60000$If$$IfF֞'08       04 Fa@!a!r!!!!0$$IfF֞'08       04 Fa$If!!!!!!!$If!!!"""6x0000$If$$IfF֞'08       04 Fa!$"%"e"q""""""<#=#O###### $_$ %%C%Y%j%w%%%%&B&N&O&e&r&&&&':'c''''''' ( (O(g(((((((()϶CJOJQJ^JmH sH H*OJQJ^JmH sH H*OJQJ^JNHOJQJ^JmH sH H*OJQJ^JmH sH OJQJ^JmH sH OJQJ^JmHsHOJQJ^JmH sH NHOJQJ^J OJQJ^J:"5":"P"Q"Z"0t$$IfF֞'08       04 Fa$IfZ"e"m"q""""$If""""""60000$If$$IfF֞'08       04 Fa"##$#%#*#0$$IfF֞'08       04 Fa$If*#5#>#F#O#q###$If######60000$If$$IfF֞'08       04 Fa#### $ $0$$IfF֞'08       04 Fa$If $ $^$_$j$u$$$$$$$$$If $$$5/$If$$IfF4֞'08       0[84 Fa$$$ %%%1%C%X%$Ifa$$IfF48[8   0[84 FaX%Y%d%j%s%w%60000$If$$IfF֞'08       0[84 Faw%%%%%%0$$IfF֞'08       0[84 Fa$If%%%%&&'&$If'&(&3&B&P&e&6L0000$If$$IfF֞'08       0[84 Fae&r&&&&&00$$IfF֞'08       0[84 Fa$If&&&&&&&' '"'pa$$IfF48[8   0[84 Fa$If "'#'+':'C'E'6|0000$If$$IfF֞'08       0[84 FaE'c'h''''0$$IfF֞'08       0[84 Fa$If'''''''$If''''' (60000$If$$IfF֞'08       0[84 Fa ( (3(8(N(O(0$$IfF֞'08       0[84 Fa$IfO(X([(g(k(((($If((((((60000$If$$IfF֞'08       0[84 Fa((()))0L$$IfF֞'08       0[84 Fa$If))().)L)Q)e)$If)&)')()f)y)z){))))))*{*+-+]+~+++++,,I,,,, -)-;-<->-o------.0.F.a.s.....//:/L/w/////00}000000-111Y1d111(2NHOJQJ^JmH sH OJQJ^JmHsHH*OJQJ^JOJQJ^JmH sH  OJQJ^JH*OJQJ^JmH sH OJQJ^JmH sH He)f)o)r){))6L0000$If$$IfF֞'08       0[84 Fa))))))0\$$IfF֞'08       0[84 Fa$If))))))*$If***z*{**6444.$If$$IfF֞'08       0[84 Fa*********$If** +5/$If$$IfF4֞'08       04 Fa + +++(+-+K+]+}+$Ifa$$IfF48[8   04 Fa}+~+++++60000$If$$IfF֞'08       04 Fa++++++0$$IfF֞'08       04 Fa$If+,,,7,I,i,$Ifi,j,s,v,,,6`0000$If$$IfF֞'08       04 Fa,,,,,,0$$IfF֞'08       04 Fa$If,,,, --(-$If(-)-2-5-=->-60000$If$$IfF֞'08       04 Fa>-R-W-n-o--0P$$IfF֞'08       04 Fa$If---------.$Ifa$$IfF48[8   04 Fa ...6P0$If$$IfF֞'08       04 Fa..%.0.=.F.a.s..$Ifa$$IfF48[8   04 Fa......60000$If$$IfF֞'08       04 Fa...../0$$IfF֞'08       04 Fa$If////:/L/b/$Ifb/c/l/w///60000$If$$IfF֞'08       04 Fa//////08$$IfF֞'08       04 Fa$If//00 0L0Q0h0$Ifh0i0n0q0}004t....$If$$IfF+֞'08       04 Fa0000000<$$IfF֞'08       04 Fa$If0000001$If111!1-11160000$If$$IfF֞'08       04 Fa11Y1d1w1x110$$IfF֞'08       04 Fa$If1111111$If11111160000$If$$IfF֞'08       04 Fa1(2>2O2P2X20$$IfF֞'08       04 Fa$If(2>2P22222223'3;3G3S3T333333464]44444555T666666777[7n7777777 88828X8l8s8t888ز؏زززززCJOJQJ^JmH sH CJOJQJ^JCJOJQJ^JmH sH H*OJQJ^JmH sH NHOJQJ^JmH sH NHOJQJ^JmH sH OJQJ^JmH sH OJQJ^JmHsHOJQJ^JmH sH  OJQJ^J8X2s2|222222$If2222226t0000$If$$IfF֞'08       04 Fa233&3'3030l$$IfF֞'08       04 Fa$If03;3C3G3`3k33$If33333360000$If$$IfF֞'08       04 Fa3333340$$IfF֞'08       04 Fa$If444$4+4]4i44$If4444446444.^$$IfF֞'08       04 Fa4444444444445555555X5n55555S6T6_6j66$If^66666$If666660***$If$$IfF4֞'08       0[84 Fa66666$If666671H+++$If$$IfF֞'08       0[84 Fa777$7/7C7